BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2024 8:57:23 AM | Browse: 313 | Download: 806
 |
Received |
|
2024-08-14 02:42 |
|
Peer-Review Started |
|
2024-05-14 03:34 |
|
First Decision by Editorial Office Director |
|
2024-09-19 22:03 |
|
Return for Revision |
|
2024-09-19 22:03 |
|
Revised |
|
2024-10-02 01:35 |
|
Publication Fee Transferred |
|
2024-10-15 07:49 |
|
Second Decision by Editor |
|
2024-10-14 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-15 00:34 |
|
Articles in Press |
|
2024-10-15 00:34 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-31 03:09 |
|
Publish the Manuscript Online |
|
2024-11-27 08:57 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Case Report |
| Article Title |
Success of intravenous immunoglobulin and steroids in managing severe COVID-19 following lung transplantation: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yen-Shou Kuo, Kuan-Hsun Lin, Ying-Yi Chen, Yuan-Ming Tsai, Ti-Hui Wu, Hsu-Kai Huang and Tsai-Wang Huang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tsai-Wang Huang, MD, PhD, Professor, Surgeon, Surgical Oncologist, Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325 Section 2, Chenggong Rd, Neihu District, Taipei 114202, Taiwan. chi-wang@yahoo.com.tw |
| Key Words |
COVID-19; Septic shock; Intravenous immunoglobulin; Lung transplantation; Post-transplant complications; Case report |
| Core Tip |
The first successful experience indicated intravenous immunoglobulin as a valuable adjunct in managing severe coronavirus disease 2019 infection complicated with severe acute respiratory distress syndrome and septic shock in a lung transplant recipient. |
| Publish Date |
2024-11-27 08:57 |
| Citation |
Kuo YS, Lin KH, Chen YY, Tsai YM, Wu TH, Huang HK, Huang TW. Success of intravenous immunoglobulin and steroids in managing severe COVID-19 following lung transplantation: A case report. World J Transplant 2025; 15(1): 96696 |
| URL |
https://www.wjgnet.com/2220-3230/full/v15/i1/96696.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v15.i1.96696 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
